Inhibit smooth muscle actin expression in cancer-associated fibroblasts (CAFs), and suppress the production of cytokines IL-6, IL-8, CCL2, angiogenin, and osteopontin (OPN) synthesized by CAFs. The gene discussed is CCL2; the disease is cancer.